Literature DB >> 19265657

Broader implications of defining standards for the pluripotency of iPSCs.

George Q Daley, M William Lensch, Rudolf Jaenisch, Alex Meissner, Kathrin Plath, Shinya Yamanaka.   

Abstract

Mesh:

Year:  2009        PMID: 19265657     DOI: 10.1016/j.stem.2009.02.009

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


× No keyword cloud information.
  56 in total

1.  A cell surfaceome map for immunophenotyping and sorting pluripotent stem cells.

Authors:  Rebekah L Gundry; Daniel R Riordon; Yelena Tarasova; Sandra Chuppa; Subarna Bhattacharya; Ondrej Juhasz; Olena Wiedemeier; Samuel Milanovich; Fallon K Noto; Irina Tchernyshyov; Kimberly Raginski; Damaris Bausch-Fluck; Hyun-Jin Tae; Shannon Marshall; Stephen A Duncan; Bernd Wollscheid; Robert P Wersto; Sridhar Rao; Jennifer E Van Eyk; Kenneth R Boheler
Journal:  Mol Cell Proteomics       Date:  2012-04-06       Impact factor: 5.911

2.  Defining pluripotency.

Authors:  Martin F Pera
Journal:  Nat Methods       Date:  2010-11       Impact factor: 28.547

3.  Metabolome and metaboproteome remodeling in nuclear reprogramming.

Authors:  Clifford Dl Folmes; D Kent Arrell; Jelena Zlatkovic-Lindor; Almudena Martinez-Fernandez; Carmen Perez-Terzic; Timothy J Nelson; Andre Terzic
Journal:  Cell Cycle       Date:  2013-07-08       Impact factor: 4.534

4.  Teratoma formation: a tool for monitoring pluripotency in stem cell research.

Authors:  Raman V Nelakanti; Nigel G Kooreman; Joseph C Wu
Journal:  Curr Protoc Stem Cell Biol       Date:  2015-02-02

5.  Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells.

Authors:  Elayne M Chan; Sutheera Ratanasirintrawoot; In-Hyun Park; Philip D Manos; Yuin-Han Loh; Hongguang Huo; Justine D Miller; Odelya Hartung; Junsung Rho; Tan A Ince; George Q Daley; Thorsten M Schlaeger
Journal:  Nat Biotechnol       Date:  2009-10-11       Impact factor: 54.908

Review 6.  Induced pluripotent stem cells: fundamentals and applications of the reprogramming process and its ramifications on regenerative medicine.

Authors:  Bhavita Walia; Neeraj Satija; Rajendra Prashad Tripathi; Gurudutta U Gangenahalli
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

Review 7.  Methods for making induced pluripotent stem cells: reprogramming à la carte.

Authors:  Federico González; Stéphanie Boué; Juan Carlos Izpisúa Belmonte
Journal:  Nat Rev Genet       Date:  2011-02-22       Impact factor: 53.242

8.  EOS lentiviral vector selection system for human induced pluripotent stem cells.

Authors:  Akitsu Hotta; Aaron Y L Cheung; Natalie Farra; Kamal Garcha; Wing Y Chang; Peter Pasceri; William L Stanford; James Ellis
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

Review 9.  Technical challenges in using human induced pluripotent stem cells to model disease.

Authors:  Krishanu Saha; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2009-12-04       Impact factor: 24.633

Review 10.  Progress toward the clinical application of patient-specific pluripotent stem cells.

Authors:  Evangelos Kiskinis; Kevin Eggan
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.